IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 219 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $492,674 | -33.0% | 108,280 | +3.6% | 0.04% | -39.7% |
| Q2 2023 | $735,497 | -33.9% | 104,474 | -42.6% | 0.06% | -40.0% |
| Q1 2023 | $1,112,686 | -4.4% | 182,109 | 0.0% | 0.10% | +18.0% |
| Q4 2022 | $1,163,677 | -30.6% | 182,109 | +4.1% | 0.09% | -29.4% |
| Q3 2022 | $1,677,000 | +1.3% | 175,000 | +16.7% | 0.13% | +10.5% |
| Q2 2022 | $1,656,000 | -0.5% | 150,000 | +50.0% | 0.11% | 0.0% |
| Q1 2022 | $1,665,000 | – | 100,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |